• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Skin Microbiota
      • Anti-oxidant
        • Oxidative stress
        • Lipid peroxidation
        • Glutathione Stock
      • Wound Healing
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us ?
    • Subscribe to our Newsletter

review

HCS, HCA & Biology

Biomimetic Materials: In vivo-like 3D cell culture models

A review of biomaterials technologies for 3D cell culture

By Zied Souguir, 3 years3 years ago
HCS, HCA & Biology

High troughput in HCS in whole organism is the future?

Complexify cell models to improve relevance of the phenotyic assay in order to find new drugs more efficient is that’s what everyone strives to do.

By Nathalie MAUBON, 6 years4 years ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • The importance of extracellular matrix in cancers
  • Webinar “Applications for 3D in vitro models with BIOMIMESYS® Adipose Tissue and preview of future BIOMIMESYS® Skin” (April 20 & 22)
  • Lucille joins us to develop hepatocellular models and hiPSCs-derived liver organoids
  • Our next webinar with Molecular Devices : A physiologically-relevant 3D ECM for in vitro oncology research and intelligent high-content imaging of 3D models
  • In silico drug development: a perfect supplement to our in vitro 3D BIOMIMESYS technology
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell CHOPIN congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix forum labo genotoxicity HCA HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro liver meeting Microbiota microenvironment microscopy model Molecular Devices NEUROCELL3D neurotoxicity oncology Parkinson phenotypic screening picture rennes screening skin toxicology
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress